Annual report pursuant to Section 13 and 15(d)

Investment (Details)

v3.22.4
Investment (Details) - USD ($)
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Feb. 28, 2021
Schedule of Equity Method Investments [Line Items]      
DepYmed preferred shares received in sale of intellectual property $ 0 $ 316,724  
Equity in loss 400,000 200,000  
DepYmed      
Schedule of Equity Method Investments [Line Items]      
Percentage of ownership held     15.00%
Carrying value of DepYmed common shares $ 0    
Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr   99,020  
DepYmed preferred shares received in sale of intellectual property   316,724  
Total Investment   415,744  
DepYmed | Intellectual property | Other (expense) income, net      
Schedule of Equity Method Investments [Line Items]      
DepYmed preferred shares received in sale of intellectual property   $ 300,000